KIRSTEN SAWYER: Open Payments
NPI 1538550116 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 65 payments from 19 companies in 2025. Trend: 2023 $2,004 · 2024 $1,476 · 2025 $1,581
Food & beverage: $1,581
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $369 |
| Calliditas Therapeutics US Inc. | 8 | $205 |
| AKEBIA THERAPEUTICS INC | 5 | $136 |
| Amgen Inc. | 5 | $129 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $119 |
| Travere Therapeutics, Inc. | 4 | $86 |
| Lilly USA, LLC | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Vifor Pharma, Inc. | 3 | $60 |
| Aurinia Pharma U.S., Inc. | 3 | $57 |
Products named: JYNARQUE, TARPEYO, Vafseo, JARDIANCE, Kerendia, TAVNEOS, FARXIGA, Veltassa.
Industry payments across GA — which companies pay providers there.
